Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017

Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses. Tell us what you thought about this episode Continue this conversation on social! Follow us today at... https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv